Stay updated on Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial page.

Latest updates to the Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays a 403 error, replacing the study content with an error page; the additions include the 403 text and header, while the study-specific sections appear removed, indicating the EmDia information is no longer accessible.SummaryDifference22%

- Check46 days agoChange Detected- The page’s revision line now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a minor publish/update of the entry that does not change study data or eligibility.SummaryDifference0.1%

- Check53 days agoChange DetectedThe study record now includes an NIH grant/contract funding note from 2016, updating the funding attribution in the trial details.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision stamp was updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a new version of the page was published. This update does not imply changes to the study content itself.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a software/template update that does not modify the study information.SummaryDifference0.0%

Stay in the know with updates to Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial page.